Therefore, the female, transgene-negative, Chil1KO cell line (with neither LMP1 nor Chil1 to act as antigens, Fig 6E) has revealed the contribution of Chil1 in the tumour environment, in the recipients. Here, PDLIM7 is linked to neoplasm.